Functional dissection of transformation by c-Src and v-Src

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The c-src proto-oncogene is often over-expressed and activated in human cancers, suggesting its involvement in cancer progression.
• Src family kinases, including c-Src, are regulated by negative regulators like Csk (C-terminal Src kinase).

Purpose of the Study:

• To investigate the transforming potential of c-Src in mouse embryonic fibroblasts lacking Csk.
• To determine the threshold for c-Src-induced transformation based on the c-Src:Csk ratio.
• To compare the transforming mechanisms and downstream effects of c-Src with those of v-Src.

Main Methods:

• Analysis of cell transformation phenotypes (anchorage-independent growth, tumorigenicity) in Csk-deficient mouse embryonic fibroblasts with c-Src over-expression.
• Dose-dependent inhibition studies by re-expressing Csk.
• Comparison of protein phosphorylation profiles and gene expression changes induced by c-Src versus v-Src.
• In vivo tumor growth and angiogenesis assessment.

Main Results:

• c-Src over-expression induced transformed phenotypes in Csk-deficient cells, with transformation being dependent on the c-Src:Csk ratio.
• c-Src induced limited protein phosphorylation and gene expression changes compared to v-Src.
• Key v-Src targets like STAT3 were not significantly activated by c-Src.
• Genes such as cyclin D1 and HIF-1alpha, involved in cancer progression, were induced by v-Src but not c-Src.
• c-Src tumors exhibited slower growth and hematoma formation, contrasting with v-Src tumors' aggressive growth and angiogenesis.

Conclusions:

• c-Src possesses cell transformation potential, but its oncogenic activity is modulated by the c-Src:Csk ratio.
• c-Src-induced transformation is distinct from v-Src, with a more restricted molecular and cellular impact.
• Additional pathways are likely required for c-Src to fully promote tumor progression in vivo.